meglumine and alpha-Galactosidase A Deficiency

meglumine has been researched along with alpha-Galactosidase A Deficiency in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdel-Gadir, A; Baig, S; Edwards, NC; Hughes, D; Kozor, R; Lachmann, RH; Lobascio, I; Medina-Menacho, K; Mehta, A; Moon, JC; Murphy, E; Nordin, S; Ramaswami, U; Sado, DM; Steeds, RP1
Banypersad, SM; Captur, G; Elliott, PM; Flett, AS; Fontana, M; Hughes, D; Lachmann, RH; Maestrini, V; Mehta, A; Moon, JC; Murphy, E; Neubauer, S; Piechnik, SK; Robson, MD; Sado, DM; Treibel, T; White, SK1

Other Studies

2 other study(ies) available for meglumine and alpha-Galactosidase A Deficiency

ArticleYear
Proposed Stages of Myocardial Phenotype Development in Fabry Disease.
    JACC. Cardiovascular imaging, 2019, Volume: 12, Issue:8 Pt 2

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Cardiomyopathies; Child; Contrast Media; Disease Progression; Fabry Disease; Female; Humans; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Myocardium; Organometallic Compounds; Phenotype; Predictive Value of Tests; Prognosis; Prospective Studies; Sex Characteristics; Sex Factors; Sphingolipids; Ventricular Function, Left; Ventricular Remodeling; Young Adult

2019
Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping.
    Circulation. Cardiovascular imaging, 2013, May-01, Volume: 6, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Case-Control Studies; Contrast Media; Diagnosis, Differential; Fabry Disease; Female; Humans; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Myocardium; Organometallic Compounds; Predictive Value of Tests; Prospective Studies; Risk Factors; Young Adult

2013